MIT study: Amino acid cysteine helps repair intestinal damage

The Story

MIT researchers have identified the amino acid cysteine, found in protein-rich foods, as a trigger for intestinal repair. In mice, a cysteine-rich diet activated immune cells that released healing signals, helping stem cells rebuild damaged intestinal tissue after radiation exposure. The discovery could lead to new dietary therapies for cancer patients with gut damage from treatment.

Key Facts

• MIT scientists discovered that cysteine, an amino acid in foods like meat, dairy, beans, and nuts, can activate an immune response that boosts intestinal stem cells.
• The study, published in Nature, is the first to identify a single nutrient capable of directly enhancing intestinal stem cell regeneration.
• When intestinal cells absorb cysteine, they convert it into CoA, which is released into the intestinal lining and absorbed by CD8 T cells, causing them to produce IL-22, a cytokine that aids intestinal repair.
• Mice fed a cysteine-rich diet showed improved recovery from radiation-related intestinal damage.
• Unpublished experiments found similar regenerative benefits after treatment with the chemotherapy drug 5-fluorouracil.
• The effect was largely limited to the small intestine because that is where most dietary protein is absorbed.
• Researchers say dietary cysteine appears to have a stronger effect on the intestine than cysteine produced by the body because it reaches the gut directly.
• The team is exploring whether cysteine can stimulate hair follicle repair and regrowth.

Conflicting Reports

No conflicting reports identified in the source article.

Still Unclear

The article does not specify whether the findings in mice will translate to humans or what dosage would be effective. It also does not detail the timeline for potential human trials.

Misconceptions

No widespread misconceptions addressed in the source article.

Key Figures

• Omer Yilmaz — director of the MIT Stem Cell Initiative, associate professor of biology at MIT, member of MIT’s Koch Institute for Integrative Cancer Research
• Fangtao Chi — first author of the study (referenced in journal citation and quoted in article)
• Anne Trafton — original writer of the MIT news release

Sources: ScienceDaily